Literature DB >> 40800

A preliminary study of the effects of prepeated doses of clobazam on aspects of performance, arousal and behaviour in a group of anxiety rated volunteers.

I Hindmarch.   

Abstract

Repeated doses of a 1,5 benzodiazepine, clobazam, were administered to a group of consenting volunteers. Performance on a psychomotor performance task was not impaired by repeated doses of the drug. Subjective assessments of anxiety were reduced commensurate with an increase in the level of cortical integration, measured via critical flicker fusion thresholds, suggesting that the anxiolytic activity of the drug is related to its effect on arousal. Important differences were found between the responses of high and low anxiety subjects on objective measures of performance and arousal and on self-completion analogue rating scales.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 40800     DOI: 10.1007/bf00644961

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  12 in total

1.  Critical flicker frequency (CFF) and psychotropic drugs in normal human subjects-a review.

Authors:  J M Smith; H Misiak
Journal:  Psychopharmacologia       Date:  1976-05-28

Review 2.  The effects of psychotropic drugs upon driving-related skills.

Authors:  A B Clayton
Journal:  Hum Factors       Date:  1976-06       Impact factor: 2.888

3.  Pharmacokinetics of single and multiple doses of clobazam in humans.

Authors:  W Rupp; M Badian; O Christ; P Hajdú; R D Kulkarni; K Taeuber; M Uihlein; R Bender; O Vanderbeke
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

4.  Clobazam, a 1,5-benzodiazepine, and car-driving ability.

Authors:  I Hindmarch; G W Hanks; A J Hewett
Journal:  Br J Clin Pharmacol       Date:  1977-10       Impact factor: 4.335

5.  A 1,4-benzodiazepine, temazepam (K 3917), its effect on some psychological parameters of sleep and behaviour.

Authors:  I Hindmarch
Journal:  Arzneimittelforschung       Date:  1975-11

6.  Diazepam and benzoctamlne: effects on certain objective parameters of muscular spasticity.

Authors:  Y D Lapierre; R Elie; L Tetreault
Journal:  Curr Ther Res Clin Exp       Date:  1973-08

7.  Proceedings: Drug interaction on driving skills as evaluated by laboratory tests and by a driving simulator.

Authors:  M Linnoila; M J Mattila
Journal:  Pharmakopsychiatr Neuropsychopharmakol       Date:  1973-03

8.  Immediate effects on human performance of a 1,5-genzodiazepine (clobazam) compared with the 1,4-benzodiazepines, chlordiazepoxide hydrochloride and diazepam.

Authors:  R G Borland; A N Nicholson
Journal:  Br J Clin Pharmacol       Date:  1975-06       Impact factor: 4.335

9.  Some aspects of the effects of clobazam on human psychomotor performance.

Authors:  I Hindmarch
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

10.  Pharmacological and toxicological properties of clobazam (1-phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-diketo-3H-1,5-benzodiazepine), a new psychotherapeutic agent.

Authors:  F Barzaghi; R Fournex; P Mantegazza
Journal:  Arzneimittelforschung       Date:  1973-05
View more
  5 in total

1.  Effect on postural sway of various benzodiazepine tranquillizers.

Authors:  A Patat; P Foulhoux
Journal:  Br J Clin Pharmacol       Date:  1985-07       Impact factor: 4.335

Review 2.  Psychomotor function and psychoactive drugs.

Authors:  I Hindmarch
Journal:  Br J Clin Pharmacol       Date:  1980-09       Impact factor: 4.335

3.  Effects of single oral doses of clobazam, diazepam and lorazepam on performance tasks and memory.

Authors:  A Patat; M J Klein; M Hucher
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

4.  The effects of clobazam and lorazepam on aspects of psychomotor performance and car handling ability.

Authors:  I Hindmarch; A C Gudgeon
Journal:  Br J Clin Pharmacol       Date:  1980-08       Impact factor: 4.335

Review 5.  Clobazam: a review of its pharmacological properties and therapeutic use in anxiety.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1980-09       Impact factor: 9.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.